Form 8-K - Current report:
SEC Accession No. 0001144204-16-123635
Filing Date
2016-09-12
Accepted
2016-09-12 17:00:40
Documents
23
Period of Report
2016-09-12
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v448561_8k.htm 8-K 18243
2 EXHIBIT 99.1 v448561_ex99-1.htm EX-99.1 19360
3 GRAPHIC image_001.jpg GRAPHIC 77265
4 GRAPHIC image_002.jpg GRAPHIC 80756
5 GRAPHIC image_003.jpg GRAPHIC 58626
6 GRAPHIC image_004.jpg GRAPHIC 63747
7 GRAPHIC image_005.jpg GRAPHIC 39321
8 GRAPHIC image_006.jpg GRAPHIC 40673
9 GRAPHIC image_007.jpg GRAPHIC 81566
10 GRAPHIC image_008.jpg GRAPHIC 65340
11 GRAPHIC image_009.jpg GRAPHIC 43758
12 GRAPHIC image_010.jpg GRAPHIC 63845
13 GRAPHIC image_011.jpg GRAPHIC 42118
14 GRAPHIC image_012.jpg GRAPHIC 27334
15 GRAPHIC image_013.jpg GRAPHIC 26815
16 GRAPHIC image_014.jpg GRAPHIC 28761
17 GRAPHIC image_015.jpg GRAPHIC 42052
18 GRAPHIC image_016.jpg GRAPHIC 38193
19 GRAPHIC image_017.jpg GRAPHIC 46801
20 GRAPHIC image_018.jpg GRAPHIC 26986
21 GRAPHIC image_019.jpg GRAPHIC 27428
22 GRAPHIC image_020.jpg GRAPHIC 30116
23 GRAPHIC image_021.jpg GRAPHIC 33333
  Complete submission text file 0001144204-16-123635.txt   1397740
Mailing Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054
Business Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

EIN.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37758 | Film No.: 161881449
SIC: 2834 Pharmaceutical Preparations